Evo Visian® ICL Launches in the U.S.; an Evolutionary Vision Correction Procedure to Treat Nearsightedness is Now Available at Coastal Vision Medical Group
Olympic Ophthalmics Announces FDA Clearance and Availability of Its Next-Generation iTEAR100 Neurostimulation Device, Expanded Patent Portfolio, and Further Clinical Studies
Harvard Eye Associates Surgeons Implant the First U.S. AccuraSee™ IOPCL to Treat Macular Degeneration
Physician Growth Partners Advises Associates in Ophthalmology in a Partnership With Spectrum Vision Partners
